J Karalliedde
Overview
Explore the profile of J Karalliedde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karalliedde J, French O, Burnhill G, Malhotra B, Spellman C, Jessel M, et al.
Diabetes Res Clin Pract
. 2023 Jul;
203:110834.
PMID: 37478978
Background And Aims: The backlog of care in resource stretched healthcare systems requires innovative approaches to aid clinical prioritisation. Our aim was to develop an informatics tool to identify and...
2.
Maltese G, Basile G, Meehan H, Fuller M, Cesari M, Fountoulakis N, et al.
J Nutr Health Aging
. 2022 Feb;
26(2):169-173.
PMID: 35166310
Background: Diabetic Foot Ulcers (DFUs) are a common and feared complication of type 1 and type 2 diabetes. People with DFUs often present a significant clinical complexity due to multimorbidity,...
3.
Banerjee D, Winocour P, Chowdhury T, De P, Wahba M, Montero R, et al.
BMC Nephrol
. 2022 Jan;
23(1):9.
PMID: 34979961
People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor in...
4.
Maltese G, Fountoulakis N, Drakatos P, Shah D, Patel K, Sharma A, et al.
Diabet Med
. 2018 Jul;
35(11):1494-1498.
PMID: 30022522
Aims: To assess the prevalence of risk factors for obstructive sleep apnoea in people with diabetic foot ulcers and to determine whether this risk predicts diabetic foot ulcer healing. Methods:...
5.
Fountoulakis N, Dunn J, Thomas S, Karalliedde J
Diabet Med
. 2017 Jun;
34(10):1483-1486.
PMID: 28636760
Background: People with gastroparesis who develop treatment-resistant (refractory) disease pose a difficult challenge, especially in the setting of end-stage renal disease (ESRD) or post pancreas transplant. Aprepitant (a neurokinin-receptor antagonist)...
6.
Guess N, Vasantharajah L, Gulliford M, Viberti G, Gnudi L, Karalliedde J, et al.
Prev Med
. 2016 Jul;
90:193-200.
PMID: 27404575
The objectives of a stage-matched approach to lifestyle change are that individuals progress forward through the stages of change. It also posits that progression through the stages of change is...
7.
Karalliedde J, Vijayanathan S, Thomas S
Diabet Med
. 2010 Jul;
27(8):958-9.
PMID: 20653755
Background: Macro- and microvascular complications of diabetes are varied and can present with a range of clinical signs and symptoms. Diabetic muscle infarction is a rare vascular complication of diabetes...
8.
9.
Karalliedde J, Viberti G
J Hum Hypertens
. 2006 Feb;
20(4):239-53.
PMID: 16452996
The incidence of end-stage renal disease (ESRD) is rising worldwide, accompanied by corresponding increases in the risk of morbidity and mortality. Underlying this trend are increasing rates of hypertension and...
10.
Ramracheya R, Muller D, Wu Y, Whitehouse B, Huang G, Amiel S, et al.
Diabetologia
. 2006 Jan;
49(2):321-31.
PMID: 16416272
Aims/hypothesis: This study aimed to identify the expression of angiotensin II receptors in isolated human islets and beta cells and to examine the functional consequences of their activation. Materials And...